News & Views
Thermo Fisher Scientific Continues Investment in Global Manufacture of Bioprocessing Products
Oct 22 2010
Thermo Fisher Scientific Inc has extended its state-ofthe-art manufacturing capability in Shanghai, China, for the production of Thermo Scientific Nunc Cell Factory single-use, certified-sterile bioprocessing systems. This announcement forms part of a continuing strategy of global investment in the regional production of its high-quality bioprocessing products, to support the local bioproduction of vaccines, cell and protein therapeutics.
The Shanghai facility complements the Nunc™ Cell Factory production sites in Rochester, New York, and Roskilde, Denmark. Commenting on the new investment, Chuck Kummeth, President of the Laboratory Consumables Division of Thermo Fisher Scientific said, “The Rochester, Roskilde and Shanghai sites are designed to meet local and international demands both now and in the future, and will facilitate the effective streamlining and continuity of supply for our growing customer base.
Our aim is to provide regional biopharma production sites with the fastest and most efficient delivery of cell culture consumables, and to enable us to do this, we are currently investing heavily in the APAC region in particular.”
Thermo Scientifics bioprocessing products portfolio is complemented by media supplements, process liquids and cell culture sera, and the extended production facilities in Shanghai follows a recently opened site in
Beijing dedicated to the hydration of cell culture media, and a joint venture in Lanzhou, China, for the collection, processing and selling of serum into local markets.
Further multi-million dollar investments have been made at production sites based in Cramlington, UK and Logan, Utah.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Nov 27 2024 Istanbul, Turkey
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE